Table 1.
Preoperative baseline characteristics of patients in the steatotic and non‐steatotic donor liver groups
| Overall (n = 763) | Steatotic donor liver (n = 309) | Non‐steatotic donor liver (n = 454) | P‐value | |
|---|---|---|---|---|
| Age (years) | 48.78 ± 10.23 | 49.61 ± 9.63 | 48.22 ± 10.59 | 0.064 |
| Male | 651 (85.3%) | 264 (85.4%) | 387 (85.2%) | 0.941 |
| Living donor | 24 (3.1%) | 2 (0.6%) | 22 (4.8%) | 0.001* |
| HBV infection | 666 (87.3%) | 263 (85.1%) | 403 (88.8%) | 0.137 |
| HCV infection | 23 (3.0%) | 11 (3.6%) | 12 (2.6%) | 0.467 |
| BMI (kg/m2) | 23.06 ± 2.40 | 23.28 ± 2.28 | 22.91 ± 2.48 | 0.037* |
| History of hypertension | 72 (9.4%) | 29 (9.4%) | 43 (9.5%) | 0.968 |
| Preoperative liver function (Child–Pugh) | ||||
| A | 465 (60.9%) | 177 (57.3%) | 288 (63.4%) | 0.059 |
| B | 202 (26.5%) | 90 (29.1%) | 112 (24.7%) | |
| C | 96 (12.6%) | 42 (13.6%) | 54 (11.9%) | |
| MELD score | 12.13 ± 6.10 | 12.58 ± 6.14 | 11.82 ± 6.06 | 0.113 |
| Preoperative FPG (mmol/L) | 4.94 ± 0.79 | 5.00 ± 0.81 | 4.90 ± 0.77 | 0.104 |
| Preoperative TC (mmol/L) | 3.88 ± 0.90 | 3.82 ± 0.81 | 3.92 ± 0.96 | 0.170 |
| Preoperative TG (mmol/L) | 1.03 ± 0.37 | 1.03 ± 0.37 | 1.03 ± 0.37 | 0.748 |
| Preoperative liver cirrhosis | ||||
| No | 71 (9.3%) | 25 (8.1%) | 46 (10.1%) | 0.341 |
| Yes | 692 (90.7%) | 284 (91.9%) | 408 (89.9%) | |
Data are mean ± standard deviation or n (%). P‐values refer to comparisons between steatotic and non‐steatotic donor liver groups. *P < 0.05. BMI, body mass index; FPG, fasting plasma glucose; HBV, hepatitis B virus; HCV, hepatitis C virus; MELD, model for end‐stage liver disease; TC, total cholesterol; TG, total triglycerides.